Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H24N2O2 |
| Molecular Weight | 324.4168 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(C=C1)N=CC=C2C(=O)CC[C@@H]3CCNC[C@@H]3C=C
InChI
InChIKey=DKRSEIPLAZTSFD-LSDHHAIUSA-N
InChI=1S/C20H24N2O2/c1-3-14-13-21-10-8-15(14)4-7-20(23)17-9-11-22-19-6-5-16(24-2)12-18(17)19/h3,5-6,9,11-12,14-15,21H,1,4,7-8,10,13H2,2H3/t14-,15+/m0/s1
| Molecular Formula | C20H24N2O2 |
| Molecular Weight | 324.4168 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Viquidil is an isomer of quinidine and papaverine derivative. Viquidil is used for treatment of disturbances of cerebral blood flow and metabolism. Viquidil, however, appeared to be approximately twice as potent as papaverine in inhibition of thrombus formation in the microvasculature and was apparently without toxic side-effects.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:08:16 GMT 2025
by
admin
on
Mon Mar 31 18:08:16 GMT 2025
|
| Record UNII |
48T4S8667S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
||
|
NCI_THESAURUS |
C47793
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
201-540-1
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
C152896
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
SUB00081MIG
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
48T4S8667S
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
3646
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104506
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
3059
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
m11469
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | Merck Index | ||
|
C100255
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
100000079324
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
DTXSID401016739
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
65753
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | |||
|
39580
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY | RxNorm | ||
|
84-55-9
Created by
admin on Mon Mar 31 18:08:16 GMT 2025 , Edited by admin on Mon Mar 31 18:08:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
